Thus, we searched for germinal variants in ASXL1, CHD1, IDH1, SETD2 and TET2 epigenetic genes in Polish prostate cancer patients and controls and analyzed the impact of them on disease clinical course, including overall survival time. The gene discussed is SETD2; the disease is prostate cancer.